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Infection of human primary renal epithelial cells with HIV-1 from
children with HIV-associated nephropathy. Children affected with human
immunodefficiency virus (HIV)-associated nephropathy (HIVAN) usually
develop significant renal glomerular and tubular epithelial cell injury. The
pathogenesis of these changes is not clearly understood. Human renal
tubular epithelial cells (RTEc) do not express CD4 surface receptors, and
it is not clear whether these cells can be infected by HIV-1. Certain strains
of HIV-1, however, have been shown capable of infecting CD4-negative
epithelial cell lines. We hypothesized that the inability of laboratory
strains of HIV-1 to infect renal epithelial cells may be due to a limited
tropism, as opposed to wild-type viruses derived from children with
HIVAN, and that viruses derived from these children are capable of
infecting RTEc from the same patient. Here, we have demonstrated that
HIV-1 isolates from children with HIVAN can productively infect RTEc
through a CD4 independent pathway, and that infected mononuclear cells
can transfer the virus to human RTEc. Human RTEc sustained low levels
of viral replication and HIV-1 inhibited the growth and survival of
cultured human RTEc. Thus, HIV-1 may directly induce degenerative
changes in RTEc of children with HIVAN. Infected macrophages may
play a relevant role in this process by transferring viruses to RTEc.
Human immunodeficiency virus (HIV)-associated nephropathy
(HIVAN) is a clinicopathologic entity that includes proteinuria,
focal segmental or global glomerulosclerosis and tubulointerstitial
disease [1–5]. The prevalence of HIVAN is highest among
African-Americans [6, 7]. While no single morphological feature
is specific of HIVAN, the swelling of glomerular visceral epithelial
cells and severe tubular microcystic dilation leading to kidney
enlargement are prominent findings of HIVAN [1–5, 8]. Although
the pathogenesis of these changes is unknown, HIV-1 may have
direct cytotoxicity by infecting renal epithelium or by inducing the
release of cytokines, viral proteins, or a combination of any of the
above. Studies in HIV-1 transgenic mice support the hypothesis
that HIV-1 gene products can injure renal epithelium even in the
absence of immunosupression or productive viral infection [9–11].
Human studies attempting to detect a productive infection of
HIV-1 in human glomerular and tubular epithelium, however,
have been inconclusive [12–15].
Human renal epithelium does not express CD4 receptors, and
in vitro attempts to infect glomerular epithelial cells using labo-
ratory strains of HIV-1 have proven fruitless [16]. Nevertheless,
certain strains of HIV-1 have been shown capable of infecting
CD4-negative human cells including fibroblasts [17, 18], neural
cells [19, 20], transformed colonic epithelial cells [21, 22], tropho-
blast [23] and cervical epithelial cells (ME180) [24–26]. These
studies indicate that other molecules can facilitate HIV-1 infec-
tion in CD4-negative cells [27–29]. A G protein-coupled receptor
named CXCR4 [30] and the chemokine receptors CCR5, CCR2b
and CCR3 [31–33] are recently described co-factors necessary for
viral entry even in the presence of the CD4 receptor and may play
a role in HIV-1 infection of CD4-negative cells. Thus, it is possible
that HIV-1 may adapt to host tissues by using cell surface
receptors or by acquiring adhesion molecules from host cells [29]
and gaining a selective tropism to infect these cells.
We hypothesized that the inability of HIV-1 to infect renal
epithelial cells may be due to a limited tropism of cloned
laboratory strains, as opposed to wild-type virus, and that HIV-1
isolates derived from children with HIVAN are capable of
infecting renal tubular epithelial cells derived from the same
patient. This study demonstrates that HIV-1 can infect renal
epithelial cells and supports the hypothesis that HIV-1 may cause
direct cytotoxicity of renal epithelial cells from children with
HIVAN.
METHODS
Isolation of primary HIV-1 viruses
Primary HIV-1 isolates were initially derived from peripheral
blood mononuclear cells (PBMCs), from three patients and from
the peritoneal fluid of one additional patient after informed
consent was obtained (Table 1). HIV-1 (SP-PF1) and (BS-3) were
isolated from two children with HIVAN also affected with
hemolytic uremic syndrome (HIVAN-HUS). HIV-1 (RW-2) was
isolated from a child with HIV-HUS, and DC-4 from a child with
HIVAN. All children with HUS were in renal failure. This study
was approved by the Children’s Hospital Institutional Review
Board. PBMCs were separated on Ficoll-Hypaque gradients and
propagated in 10 ml RPMI-1640 medium containing 10% heat-
inactivated fetal bovine serum, 5% interleukin-2 and 5 mg/ml
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PHA from Cellular Products (Buffalo, NY, USA). PBMCs (1 3
107) and peritoneal cells (5 3 106) were co-cultured with 1 3 107
mitogen-stimulated normal human PBMCs from healthy HIV-1
negative donors. The culture media was changed every three days.
All cultures were fed with fresh HIV-1 negative PBMC (5 3 106)
once a week. The HIV-1 IIIB isolate from Dr. Robert Gallo [37]
was obtained through the AIDS Research and Reference Reagent
Program (Division of AIDS, NIAID, NIH, Bethesda, MD, USA).
Samples from infected PBMCs and cell-free supernatants were
frozen and saved. Virus supernatants were harvested from in-
fected PBMCs and titrated simultaneously by limiting dilution on
HIV-1 negative PBMCs. The viabilities of these cultures were
monitored by vital dye exclusion as described previously by Pise,
Newburger and Holland [38]. Only, cultures yielding infectious
titers of . 106 TCID50/ml were used.
Renal tubular epithelial cell cultures
Primary renal tubular epithelial cells (RTEc) were isolated
from renal biopsies, autopsies, and urine of five children with
HIV-associated renal disease. RTEc cultures were established as
described previously [34], by cloning homogeneous micro-colonies
of RTEc on collagen I-coated dishes. RTEc exhibit a character-
istic epithelial morphology, growing in cobblestone-like monolay-
ers (Fig. 1). They lack Factor VIII-related antigen, characteristic
of endothelial cells, and express cytokeratin, g-GTP, or other
markers of cell differentiation depending on each specific RTEc
type [34]. To preferentially enhance the growth of proximal
tubular cells, which are capable of endocytosis, a potential mech-
anism of HIV-1 viral entry into the cells, all primary colonies were
plated on collagen-coated plastic dishes and grown in the follow-
ing selective renal proximal tubule culture medium: Click RPMI
(Quality Biological Inc. Gaithersburg, MD, USA), supplemented
with 1% fetal bovine serum (Lot #A9234J; Gemini Bioproducts,
Calabasas, CA, USA), 5 ml/500 ml (100 xpen/strep), 1 mM Hepes,
2 mM L-glutamine, insulin (5 mg/ml), transferrin (5 mg/ml), and
dexamethasone 5 3 1028 M, obtained from Sigma (St. Louis, MO,
USA). Insulin was omitted in collecting tubule culture media. All
cells were used between passages 1 and 3 while retaining epithelial
characteristics. RTEc were also isolated from HIV-negative chil-
dren (Table 2). The diagnosis of HIV infection was excluded
based on the clinical history and HIV-1 serology. HIV-1 serology,
however, was not available in two patients. All RTEc derived from
children not infected with HIV-1 were screened by HIV-1 PCR
and p24 antigen measurements in culture supernatants. RTEc
derived from proximal, thick ascending limb of Henle, and distal
convoluted tubules were generously provided by Dr. Patricia
Wilson (Mount Sinai Medical Center, New York, NY, USA).
Mouse primary RTEc were isolated and grown as previously
described [11]. The non permissive renal canine epithelial cell line
MDCK was obtained from ATCC (Rockville, MD, USA). The
HeLa-CD41 cell clone 1022 from Dr. Bruce Chesebro [35] was
obtained through the AIDS Research and Reference Reagent
Program (Division of AIDS, NIAID, NIH, Bethesda, MD, USA).
This adherent cell line was used as a positive control since HIV-1
IIIB and many primary HIV isolates derived from patients PBMC
are capable of infecting these cells [36].
To determine whether RTEc derived from HIV-infected chil-
dren were not previously infected at the outset of the experiments,
the following studies were performed: (1) polymerase chain
reaction (PCR) for HIV-1 proviral DNA; (2) p24 antigen mea-
surements in culture supernatants (p24 antigen values . 2.0 SD
above the mean from all control uninfected RTEc cells were
considered positive); (3) determined whether HIV-1 could be
rescued by co-culturing a representative sample of cells from each
clone with stimulated human HIV-1 negative PBMCs; (4) studied
selected RTEc clones by electron microscopy to exclude the
presence of viral particles. RTEc derived from HIV-infected
children were not used in other experiments if at least one of these
results was positive.
Experimental design
Each RTEc clone or cell type was divided in two groups. One
group of cells was used as control and the other group was
exposed to HIV-1. In cell-associated infection experiments, RTEc
were exposed to HIV-1 infected PBMCs. In cell-free infection
experiments, RTEc were exposed to HIV-1 infected supernatants
derived from infected PBMCs. Supernatants were filtered through
a 0.4 mm pore size membrane. Control cells were exposed to
stimulated HIV-1 negative PBMCs or uninfected supernatants.
All experiments were done in triplicate.
In typical experiments, human RTEc were plated on 24-well
plates, six-well plates, or T25 flasks, at a density of approximately
2,500 cell/cm2. RTEc were grown until they were confluent. In
cell-associated infection experiments, RTEc were exposed to
HIV-1 infected PBMCs (approximately 2.4 3 103 cells/cm2), while
in cell-free infection experiments, RTEc were exposed to HIV-1
infected supernatants [. 1 3 107 infection units (IU)/ml]. Since
we did not use dextran or polybrene to facilitate the infection
process, high viral titers were used, ranging from 1 to 10 MOIs, in
all experiments unless indicated otherwise. RTEc were exposed to
HIV-1 for 24 to 48 hours. Cells were then washed three times to
remove the input virus and refed with fresh culture media.
Cultures were followed for a minimum period of three weeks.
Two additional washes and culture media changes were done
during this period. At the end of each experiment, all cells were
washed and harvested for HIV-1 studies (see infection criteria
below), or co-cultured with HIV-1 negative PBMCs to determine
whether HIV-1 could be rescued. Supernatants from control and
HIV-exposed RTEc were used to infect normal PBMCs. To
eliminate the possibility that adherent viruses were being de-
tected, non-permissive epithelial cells (MDCK and mouse renal
tubular epithelial cells) were exposed to a similar number of
infectious units in both cell free and cell-associated infection
experiments. In addition, the HIV-1 IIIB isolate, which does not
infect human epithelial cells, was used as another control to
investigate whether adherent viruses could be rescued from the
cell surface of human RTEc by PBMCs.




SP-PF1 Peritoneal fluid 6 m/F/AA
RW-2 PBMCs 12 Y/M/C
BS-3 PBMCs 6 m/F/AA
DC-4 PBMCs 8 m/M/AA
Abbreviations are: m, months; Y, years; M, male; F, female; AA,
African American; C, Caucasian, PBMCs, peripheral blood mononuclear
cells.
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Criteria to define HIV-1 infection
The following criteria were used to define RTEc infection: (1)
at least two consecutive samples with absorbance values . 2.0 SD
above the p24 antigen control values, and one cutoff p24 antigen
value of . 12.5 pg/ml after removal of input virus; (2) two
consecutive measurements detecting an increase in p24 antigen
values in the culture media after each wash; (3) positive HIV
proviral DNA by PCR in RTEc cultured for more than two weeks.
Positive cultures were defined by a cutoff value of . 800 ECL
units/1 3 106 cells (. 2.0 SD above control values). (4) Positive
HIV RNA by nucleic acid sequence based amplification
(NASBA) in mRNA extracted from RTEc cultured for more than
two weeks. Positive cultures were defined by a cutoff value of .
700 copies/1 3 106 (.2.0 SD above control values). (5) Infection of
HIV-1 negative PBMCs co-cultivated with RTEc previously ex-
posed to HIV-1 and grown in culture for more than twenty days.
All five criteria were required in both cell-free infection and
cell-associated infection experiments, and in all experiments using
RTEc isolated from HIV-infected or HIV negative children. To
confirm the presence of positive cytoplasmic HIV-1 staining in
RTEc infected in cell-associated experiments, we performed
immunohistochemistry and in situ hybridization studies. Co-local-
ization experiments were done using HIV-1 probes and immuno-
histochemical markers for mononuclear and epithelial cells by
combining in situ hybridization and immunohistochemical tech-
niques. Finally, we performed transmission electron microscopy
(TEM) studies to confirm the presence of viral particles inside
RTEc.
For blocking experiments, human renal proximal tubular epi-
thelial cells (RPTEc) were seeded at a density of 1 3 106 cells per
well. After 24 hours RPTEc were preincubated with anti-CD4
monoclonal antibodies, OKT4 from Ortho Diagnostics Systems
A
B C
Fig. 1. A. Transmission electron microscopy showing maintenance of orientation, intercellular junctions (arrows) and microvillous surface of cultured
RPTEc (32,500). (B and C) Renal tubular epithelial cells (RTEc) isolated from children with HIVAN (3160).
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(anti-V3/V4 domains; 10 mg/ml), or Leu 3a (Becton Dickinson,
Mountain View, CA, USA; 10 mg/ml) for one hour. HIV-1
infected PBMCs were preincubated with these antibodies for one
hour. RPTEc and PBMCs were co-cultured in medium containing
10 mg/ml of OKT4 or anti-Leu 3a antibodies for 12 to 24 hours.
Infection was assessed as previously described. Controls included
human RPTEc exposed to infected PBMCs in the absence of
anti-CD4 monoclonal antibodies. The presence of CD4 protein in
human RTEc was examined in cells fixed with 2% paraformalde-
hyde by fluorescein-activated cell scanning analysis, following
standard procedures and using anti-Leu 3a monoclonal antibody
(Becton Dickinson) and an isotype-matched irrelevant mouse
monoclonal antibody as a control for non-specific staining.
Trans-filter infection experiments
To determine whether macrophages were able to infect RPTEc
in the absence of cell fusion, RPTEc were seeded on permeable
Nucleopore filters (3 mm) which were placed in Transwell cell
culture chambers (Costar, Cambridge, MA, USA), above the
macrophages. Macrophages, isolated from primary PBMCs by
their ability to attach to the culture dishes, were infected with
cell-free HIV-1 (DC-4). RPTEc seeded on the upper surface of
five filters were placed in the Transwell cell culture chambers
above the infected macrophages. Controls included human
RPTEc derived from the same clone, seeded on two filters and
exposed to uninfected macrophages, as well as non permissive
MDCK cells seeded on three filters and exposed to HIV-1
infected macrophages. After 48 hours of exposure, the filters with
the attached RPTEc were transferred to new culture dishes in the
absence of macrophages, the culture media was changed, and the
cells were followed for 10 to 14 days.
P24 antigen values were measured by an antigen capture
enzyme immunoassay from Abbott Laboratory (North Chicago,
IL, USA), following the manufacturer’s directions. The upper
detection limit of the assay was 200 pg/ml.
Detection of proviral DNA by polymerase chain reaction
Electrochemiluminescent detection of the HIV-1 specific am-
plification products were measured as described by Schutzbank
and Smith [39]. Briefly, cells were removed and suspended in 250
ml of lysis buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.3, 2.5 mM
MgCl, 0.45% Nonidet P-40, 0.45% Tween 20, and 10 mg/ml
proteinase K). The lysates were incubated at 60°C for one hour,
followed by 100°C for 10 minutes to inactivate the proteinase K. A
50 ml sample of each specimen was transferred to a thin walled,
200 ml MicroAmp tube from Perkin Elmer (Norwalk, CT, USA)
containing 50 ml of amplification master mix (50 mM KCl, 10 mM
Tris-HCl, pH 8.3, 2.5 mM MgCl2, 500 mM each dNTP, 500 mM each
SK38 and SK39-biotin primers and 2.5 units of AmpliTaq DNA
polymerase (Perkin Elmer). The HIV-1 gag gene-specific PCR
primers, SK38/59 biotinylated-SK 39, and the detection probe SK
19, were synthesized by Genosys Biotechnologies Inc. (The
Woodlands, TX, USA). Each PCR study was done in the presence
of 3 negative controls (HIV-negative PBMCs) and two positive
controls (10 and 50 copies of HIV-1 proviral DNA). In addition,
control and infected human RTEc, as well as nonpermissive
epithelial cells (MDCK or mouse RTEc) were run simultaneously
in duplicates.
Detection of viral RNA by nucleic acid sequence base
amplification
RNA was extracted from control and infected renal epithelial
cells as described previously [11]. Quantification of viral genomic
RNA was performed using a commercially available HIV-1 Q
NASBA kit, from Organon Technica, (Research Triangle Park,
NC, USA) following the manufacturer’s directions.
Immunocytochemistry
For indirect immunofluoresence staining, cells were fixed in
methanol for five minutes, washed three times in PBS and
incubated for one hour at room temperature with HIV-positive
human serum diluted 1:100 in PBS containing 3% BSA. After
three washes in PBS, the coverslips were incubated for one hour
at room temperature in rabbit anti-human fluorescein isothiocya-
nate (FITC)/green (Sigma) diluted in 1:80 in PBS with 3% BSA.
Background and nonspecific staining were determined by using
mock-infected cells. For HIV-1 p24 antigen staining we used a
Kal-1 monoclonal antibody to HIV-1 p24 antigen from Dako
(Glostrup, Denmark) and a peroxidase-avidin-biotin complex
Table 2. Summary of all primary epithelial cell cultures used in this study







RW-U1 HRTEc Urine 12y/M/C Pos HIV-1-HUS Yes
RW-B1 HRPTEc Renal biopsy 12y/M/C Pos HIV-1-HUS Yes
SB-U1 HRTEc Urine 6m/F/AA Pos HIVAN/HUS Yes
SB-A1 HRTEc Autopsy 6m/F/AA Pos HIVAN/HUS Yes
DC-U1 HRTEc Urine 8m/M/AA Pos HIVAN Yes
DC-U2 HRTEc Urine 8m/M/AA Pos HIVAN Yes
RT-1 HRTEc Renal surgery 5y/M/C Neg Renal malformation Yes
RPTE-1 HRPTEc Cadaveric kidney 19y/M/C Neg Unknown Yes
RPTE-2 HRPTEc Cadaveric kidney 19y/M/Unk Neg Unknown Yes
TAL-1 HTAL Cadaveric kidney Unknown Neg Unknown Yes
DC-1 HDC Cadaveric kidney Unknown Neg Unknown Yes
M-RTEC Mouse RTEc Mouse kidney NA NA NA No
a HRTEc, human renal tubular epithelial cells; HRPTEc, human renal proximal tubular epithelial cells; HTALc, human thick ascending limb of Henle
epithelial cells; HDC, human distal convoluted tubular epithelial cells
b m, months; Y, years; M, male; F, female; AA, African American; C, Caucasian
c HUS, hemolytic uremic syndrome; HIVAN, HIV associated nephropathy
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(ABC) method from Dako [11]. All sections were counterstained
with hematoxylin. A panel of different antibodies was used to
identify the cell type infected by HIV-1; mouse monoclonal
EBM-11 (1:4,000 dilution) and KP1 anti human CD68, which
recognize monocyte/macrophages, anti-CD4, anti-CD8, leukocyte
common antigen (LCA), cytokeratin, vimentin, (all from Dako)
and a smooth muscle actin (Sigma). Goat anti-mouse IgG, as well
as other second biotinylated antibodies, mouse PAP and mouse
APAAP were obtained from Dako.
In situ hybridization
In situ hybridization studies were performed as previously
described [40], using a digoxigenin-UTP labeled RNA probe from
Lofstrands Labs, (Gaithersburg, MD, USA), generated by SP6 or
T7 polymerase transcription from 1 to 2 kb subclones spanning
the entire HIV-1 genome. Briefly, 4% paraformaldehyde fixed
human primary macrophages and RTEc cell cultures were pre-
treated with 0.2 N HCl, proteinase K and hybridized with 1.75
ng/ml of sense or antisense HIV-1 riboprobes at 52°C overnight.
Posthybridization treatment consisted of washing sequentially in
2 3 SSC/50% formamide solution at 50°C, 1 3 SSC and RNase
solution at 37°C (RNase T1 and RNase A). The samples were
blocked with 2% horse serum, 150 mM NaCl, and 100 mM Tris pH
7.4 for one hour, and stained with sheep anti-digoxigenin alkaline
phosphate conjugate (Boehringer Mannheim, Germany) 1:500,
and rinsed in Tris pH 7.4. The cells were then incubated with
NBT/BCIOP substrate from Vector Labs, (Burlingame, CA,
USA), containing 5 mM levamisole, overnight at room tempera-
ture. The stained slides were rinsed in distilled water counter-
stained with nuclear fast red, dehydrated and coverslipped. Con-
trols for in situ included: HIV-1 sense riboprobe hybridized with
HIV-1 infected cell cultures, and uninfected primary cell cultures
hybridized with HIV-1 antisense probe.
Transmission electron microscopy
RTEc were washed one time with 1 3 PBS and fixed in 3%
glutaraldehyde in a 0.2 M phosphate buffer, pH 7.2 for detection
of HIV-1. All experiments were performed in triplicate.
Changes in renal tubular epithelial cell morphology and growth
Renal tubular epithelial cells (RT-1) were seeded in six-well
plates at a density of 5 3 105 cells in 0.5 ml of RTEc culture
media. Cells on three dishes were exposed to HIV infected
supernatants (0.5 ml/1 3 107 IU/ml), while the remaining control
cells were exposed to supernatants from stimulated HIV-negative
PBMCs. After five days of exposure, all cells were washed,
trypsinized, counted, and passaged at equal cell densities (5 3 105
cells/well) into new tissue culture dishes in fresh RTEc culture
media. Morphologic changes were evaluated daily under a light
microscope. After one week, RTEc from both groups were
counted. Results were expressed as the mean 6 SD of values
obtained in duplicate from at least two different experiments.
Difference in cell number between control and HIV-1 treated
groups were compared by Student’s t-test. P values less than 0.05
were considered significant.
RESULTS
Infection of renal tubular epithelial cells derived from children
with HIVAN
To examine whether RTEc derived from children with HIVAN
were already infected with HIV-1, 35 clones were isolated from
five different children and screened by PCR for the presence of
HIV-1 proviral DNA. Two primary RTEc clones from two
different patients were positive. The possibility that these colonies
were contaminated by macrophages was excluded by (1) cloning
and expanding colonies of RTEc in selective renal proximal
tubular epithelial cell culture media; (2) performing immunohis-
tochemistry studies with antibodies against cytokeratin, macro-
phages and lymphocytes (CD-68/LCA); (3) excluding the pres-
ence of contaminating cells by light microscopy and TEM in
HIV-1 positive RTEc (Fig. 2).
To determine whether uninfected RTEc derived from children
with HIVAN were susceptible to infection with their own primary
HIV-1 isolates, RTEc were exposed to cell-associated and cell-
free HIV-1 derived from peritoneal fluid or PBMCs of the same
patients (Table 1). RTEc could be infected by their corresponding
HIV-1 isolated from the same patient at a multiplicity of infection
1 and 10. Infection was accomplished using both HIV-1-infected
PBMCs (Fig. 3) and cell-free viral supernatants (Fig. 4). Fourteen
to twenty days after co-culture, supernatant p24 antigen levels
ranged from 20 to 100 pg/ml (1 3 106 cells), which is 2 to 10 times
greater than p24 levels from HIV-1 exposed non-permissive
epithelial cells (Fig. 5). After 20 days in culture, HIV DNA PCR
and HIV RNA NASBA values in infected RTEc were increased
an average of 10 to 20 times the values of control human RTEc
not exposed to HIV-1 or of non-permissive epithelial cells ex-
posed to a similar number of infection units in both cell free and
cell associated infection experiments (Figs. 3 and 4, legends).
Human RTEc sustained low levels of productive infection, while
mouse primary renal tubular epithelial cells or the nonpermissible
renal canine epithelial cell line MDCK (Fig. 3) were not infected
by either of the two primary isolates derived from the same
patients (RW-2 and BS-3). These primary viral isolates also
infected HeLa-CD41 cells and peripheral blood-derived macro-
phages from HIV-1 negative donors, often inducing giant cell
formation (Fig. 6C), and yielding p24 antigen levels in the
macrophage culture media of above 100 pg/ml, as well as consis-
tent HIV DNA PCR values . 5,000 ECL units/1 3 106 cells and
HIV-RNA NASBA values . 20,000 copies/1 3 106 cells. In three
experiments, infected human primary RTEc were detached and
passaged onto collagen I coated dishes, but they subsequently lost
their p24 antigen values, PCR-detectable DNA, and HIV-RNA
(p24 , 12.5 pg/ml; HIV-PCR DNA , 1,000 ECL units; HIV-
RNA , 700 copies/per 1 3 106 cells, respectively) after three
weeks in culture, suggesting that there can be a transient HIV-1
infection and/or that infected cells do not survive tissue culture
passages.
Infection of renal tubular epithelial cells derived form HIV-1
negative patients
To ascertain whether RTEc from HIV-1 negative patients were
also susceptible to infection, epithelial cells derived from proximal
thick ascending limb of Henle, and distal convoluted tubules, were
exposed to HIV-1. Two primary HIV-1 isolates from children with
HIVAN, HIV-1 DC-4 and RW-2, were able to infect RTEc from
HIV-negative children at MOIs ranging from 1 to 10. In all
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experiments nonpermissive MDCK cells and control human
RTEc showed HIV DNA PCR values consistently , 800 ECL
units/1 3 106 cells, and HIV RNA NASBA values , 700
copies/1 3 106 cells. Infected human RTEc showed consistent
HIV-DNA PCR values . 2,600 ECL units/1 3 106 cells, and HIV
RNA NASBA values . 2,500 copies/1 3 106 cells. In two different
experiments human renal proximal tubular epithelial cells
(RPTEc) were not infected by the T-lymphotropic IIIB laboratory
strain, while HeLa CD41 cells subjected to a similar infection
protocol were infected. Multiple PBMC passages of primary viral
isolates from patients with HIVAN decreased their ability to
infect human RTEc, since RPTEc exposed to HIV-1 RW-2
(which was passaged 5 times in PBMCs) showed p24 antigen
levels , 12.5 pg/ml in the culture supernatants and viruses could
not be rescued from these cells, after three weeks in culture.
Mechanisms of renal tubular epithelial cell infection
To investigate the role of the CD4 receptor during HIV-1
infection of RTEc, we attempted to block infection by using
anti-CD4 antibodies. Infection of human RTEc was not inhibited
by OKT4 or anti-Leu 3a monoclonal antibodies. In agreement
with these results, we did not find CD4 receptors in cultured
human RTEc by flow cytometry and Northern blot analysis of poly
A1 mRNA (data not shown). These findings suggest that HIV-1
enters RTEc by CD4 independent pathways.
Trans-filter experiments
To determine whether macrophages were able to infect renal
proximal tubular epithelial cells (RPTEc) in the absence of cell
fusion, RPTEc were cultured on permeable filters, which were
Fig. 2. Low (A) and higher magnification (B) transmission electron
microscopy (TEM) of macrophages infected with HIV-1 from a child with
HIVAN (HIV-1 DC-4). Virions are budding from the complicated plasma
membrane (B, small arrow) and into cytoplasmic vacuoles (B, arrowhead
while mature particles are within the same vacuoles and accumulating on
the cell surface (A, B, larger arrows). (C) High magnification of a virion
budding from the surface of another macrophage. A mature particle
appears to be partially within a coated pit (A, 34,000; B, 324,000, C,
3105,000).
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then placed in culture chambers allowing independent access to
either the apical or basal surfaces. HIV-1 infected macrophages
were cultured in the lower chamber, beneath the uninfected
RPTEc that were seeded on the upper surface of the filters. After
48 hours of incubation, the filters with the attached RPTEc were
transferred to fresh dishes and cultured for 10 to 14 days. Three
of five human RPTEc cultures became infected with HIV-1, while
none of three control MDCK cell cultures was infected based on
the same infection criteria described in the Methods section.
Transmission electron microscopy studies
Productively-infected lymphocytes and macrophages came into
intimate contact with the surface of epithelial cells (Figs. 7 and 8),
and virions were detected in the intervening space and within
cytoplasmic vacuoles of macrophages and RTEc (Fig. 7, A-C).
Infection of renal epithelium was more effective in the presence of
intimate contact of mononuclear cells and RTEc.
Growth of renal tubular epithelial cells exposed to HIV-1
Renal tubular epithelial cells exposed to HIV-1 infected super-
natants showed significant evidence of injury and decreased
growth rates. Under light microscopy (Fig. 9), epithelial cell injury
was manifested by the loss of cell to cell contacts, acquisition of
spindle morphology, decreased growth rates, increased cell de-
tachment from the culture dish, and eventually necrosis. Injury
was confirmed by TEM and apparently not limited to infected
cells, suggesting that other factors produced by HIV-1 infected
PBMCs may have a role in this process. Two different experi-
ments using different primary viral isolates (DC-4 and RW-2)
showed a significant reduction in the final number of cells exposed
to HIV-1 (3.6 6 0.3 3 106 cells/well in control, vs. 2.1 6 0.2 3 106
cells/well in HIV-1 exposed cells (P , 0.001).
DISCUSSION
Distinctive histologic features of HIVAN are the swelling of
visceral glomerular epithelial cells, atrophy of tubular epithelium,
Fig. 3. Cell-to-cell associated infection of human primary renal tubular
epithelial cells (RTEc). RTEc (1 3 106) derived from a child with HIVAN
(RW) were exposed to 3 3 105 PBMC, infected with either HIV-RW-2, a
viral isolate from the same patient (RW), or HIV-BS-3, a viral isolate
corresponding to another child with HIVAN (BS). Cultured cells were
followed for a period of three weeks as described in the Methods section.
The arrows point to p24 antigen values measured immediately after 3
washes. Since the upper limit of detection of the p24 assay was 200 pg/ml,
the scale was interrupted at this value. To eliminate the possibility that
adherent viruses were being detected, experiments were controlled by
exposing MDCK cells (a nonpermissible renal canine epithelial cell line
(ATCC) or mouse primary RTEc (data not shown), to the same viruses.
MDCK-1 or MDCK-2 exposed to HIV-1 RW-2 and HIV-BS-3 respec-
tively, remained uninfected. On day 20, HIV-1 DNA PCR values in
control samples were , 800 ECL units/1 3 106 cells and HIV RNA
nucleic acid sequence base amplification (NASBA) values , 700 copies/
1 3 106 cells. Infected cells showed mean HIV-1 DNA PCR values of
8,900 6 1,110 ECL units/1 3 106 cells and HIV RNA NASBA values
16,000 6 2,230 copies/1 3 106. Symbols are: (F) RTEc (RW)-HIV-1
(RW-2); () RTEc (RW)-HIV-1 (BS-3); (E) MDCK1-HIV-1 (RW-2);
() MDCK2-HIV-1 (BS-3).
Fig. 4. Cell free infection of human primary renal tubular epithelial cells
(RTEc). RTEc derived from a child with HIVAN (BS) were exposed to 0.5
ml of cell free virus (.1 3 107 IU/ml) derived from peripheral blood
mononuclear cell (PBMC) cultures infected with HIV-1 (BS-3; F), a viral
isolate from the same patient (BS), or HIV-1 (RW-2; ), the viral isolate
corresponding to another child with HIVAN (RW). BS-RTEc, exposed to
uninfected PBMC’s supernatants were used as control cells [Mock-
infected 1 (E) and Mock-infected 2 ()]. RTEc were infected simulta-
neously with each particular stock of virus. After 24 to 48 hours exposure,
cells were washed three times to remove the input virus and refed with
fresh culture media and followed for a period of three weeks as described
in the Methods section. The amount of HIV-1 p24 antigen production was
measured every two-three days by ELISA. The arrows point to p24 antigen
values measured immediately after three washes. Since the upper limit of
detection of the p24 assay was 200 pg/ml, the scale was interrupted at this
value. Experiments were terminated by testing the ability of RTEc to
infect normal HIV-1 negative PBMC. All infected RTEC were able to
infect co-cultured PBMC, while uninfected RTEc did not. On day 20
HIV-1 DNA PCR values in control samples were , 800 ECL units/1 3 106
cells and HIV RNA NASBA values , 700 copies/1 3 106 cells. Infected
cells showed mean HIV-1 DNA PCR values of 2,300 6 570 ECL units/1 3
106 cells, and mean HIV RNA NASBA values of 6,400 6 1,008 copies/1 3
106 cells.
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and microcystic tubular dilation. An important question remain-
ing to be answered, is whether HIV-1 can productively infect and
injure renal epithelial cells. In the present study, we isolated
primary renal tubular epithelial cells from children with HIVAN
and exposed them to the viral isolates derived from the same
patients. Our results provide a strong evidence to support the
hypothesis that HIV-1 is capable of infecting and injuring renal
tubular epithelial cells.
HIV-1 can enter epithelial cells by three possible routes:
binding of cell-free virus to specific receptors, fusion with infected
mononuclear cells, and direct transfer during intimate contact
between productively-infected mononuclear cells and epithelial
cells [24, 25]. In the last two instances, the virus is isolated from
the immune system of the host. In agreement with the third
mechanism, Phillips and co-workers [25, 26] showed that HIV-1
infected mononuclear cells interact with specific binding sites on
cervical epithelial cells (MT180), and release viruses into the
intervening space. We found that all primary viral isolates capable
of infecting RTEc could infect macrophages. Productively-in-
fected lymphocytes and macrophages came into intimate contact
with the surface of epithelial cells and virions were detected in the
intervening space and within cytoplasmic vacuoles of macro-
phages and renal epithelial cells. Thus, considering the high viral
titers needed to infect cultured RTEc, the renal epithelium in vivo
may be more likely to be infected from intimate contact of
mononuclear cells and RTEc.
The mechanism(s) responsible for HIV-1 infection of RTEc is
not completely understood at the present time. Green, Resnick
and Bourgoignie were unable to infect cultured renal glomerular
epithelial cells from one patient using a low passage clinical strain
of HIV-1 isolated from a patient with AIDS and the T-lympho-
tropic IIIB laboratory strain of HIV-1 [16]. We could not infect
RPTEc by using the T-lymphotropic laboratory strain of HIV-1
IIIB. Results from both studies, however, are difficult to compare,
since in addition to different renal epithelial cell type, we have
used primary isolates and RTEc derived from children with renal
Fig. 5. Immunostaining of primary human renal tubular epithelial cells (RTEc) infected with HIV-1 isolates derived from children with HIVAN in cell
associated infection experiments. (B, C and D) demonstrate HIV-1 p24 antigen staining detected in the cytoplasm of human RTEc using a Kal-1
monoclonal antibody to HIV-1 p24 antigen (Dako) (B 3200, C 3630, D 3400) and a peroxidase-avidin-biotin complex (ABC). (A) Uninfected RTEc
exposed to the same antibody (3100). All sections were counterstained with hematoxylin.
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™3
Fig. 6. In situ hybridization studies performed on primary macrophages and RTEc derived from children with HIVAN and infected with their
corresponding primary isolates in cell associated infection experiments. (A) Infected renal tubular epithelial cells (RTEc) hybridized with HIV-1 sense
probe (3100). (B and D) Different magnifications of infected RTEc hybridized with HIV-1 antisense probe. Positive HIV-1 RNA was detected within
the cytoplasm of some RTEc (B 3100 and D 3360). (C) Colocalization of HIV-1 RNA (blue) by in situ hybridization in cultured macrophages, which
are stained red by immunohistochemistry using an antibody against CD-68 antigen (C 3360). (E) Cytokeratin expression in renal tubular epithelial cells
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by immunohistochemistry (3500). (F) Colocalization of HIV-1 RNA (blue) and cytokeratin (red) within the cytoplasm of a RTEc stained by ISH and
IHC (F 3800). (G) Control human RTEc hybridized with HIV-1 antisense probe (G 3100). (H) A co-localization study of HIV-RNA by in situ
hybridization (blue) and mononuclear cells (red) by immunohistochemistry, using an anti-CD-68 antibody which stains mononuclear cells (arrow). Note
HIV-RNA cytoplasmic staining in human RTEc that are not stained (H 3360).
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disease, higher infection units, and different experimental design.
It is possible, however, that viruses from children with HIVAN
may have adapted to infect RTEc and that this capacity is lost
during passage through PBMCs. Moreover, infection of RTEc
was not significantly inhibited by anti-CD4 antibodies, suggesting
that this process is mediated by CD4 independent pathways. In
Fig. 7. Macrophage spread over portion of surface of flattened renal tubular epithelial cells (RTEc) (A). Mature HIV-1 particles are associated with
surface of macrophage (A, small arrow, upper left field and B) including in the narrow intercellular space (A, larger arrow, center of field and in C).
Several mature particles are within cytoplasmic vacuole of RPTEc (A & C open arrows). A desmosome joins lateral surface of 2 epithelial cells (A &
D solid arrowheads) (magnification: A 37,000, B 358,000, C 358,000, D 333,000).
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agreement with this result, we did not find CD4 receptors in
cultured RTEc. More studies will be required to identify the
receptors involved in this process. For example, the sulfate chains
of heparan sulfate proteoglycans (HSPG), a known facilitator of
virus adsorption [41, 42], other newly described co-receptors
[30–34], or adhesion molecules [29] may play a relevant role in
this process. Thus, HIV-1 cell tropism [43, 44], in addition to
cellular factors present in human renal epithelial cells, can
influence infection. Finally, we have demonstrated that RTEc
isolated from both African-American and Caucasian children can
be infected with HIV-1 isolates derived from children with
HIVAN. This finding suggests that other co-factors and/or genetic
predisposition of black patients, in addition to HIV-1 infection of
RTEc, may play an important role in the pathogenesis of HIVAN.
Renal tubular epithelium may be infected through basolateral
or luminal surfaces. Though HIV-1-infected cells and free virus
have been detected in the urine of patients [45], it is difficult to
culture HIV-1 from the urine or to infect RTEc with concentrated
urine samples. This evidence suggests that RTEc are more likely
to be infected through their basolateral surfaces by tissue mono-
nuclear cells. We found that RTEc cultured on permeable filters
and placed in culture chambers, which allow an independent
access to either the apical or basal surfaces, were infected by
macrophages through their basolateral surfaces and without cell-
to-cell fusion. This may be the most likely in vivo mechanism of
RTEc infection in children.
A major issue in the pathogenesis of HIVAN is whether RTEc
can actually replicate HIV-1. Transmission electron microscopy
confirmed the presence of mature virions within cytoplasmic
vacuoles in RTEc. It is possible that some viral particles may
undergo lysosomal digestion, but it is unlikely that all our results
could be accounted for solely on the basis of this process. The
detection of HIV RNA by NASBA and in situ hybridization in
RTEc, as well as the detection of proviral DNA and cytoplasmic
p24 antigen, strongly suggest that viral-specific RNA and protein
are being synthesized and that RTEc are productively infected.
That PBMCs cocultured with cell-free infected RTEc themselves
become productively infected also support this contention. Our
failure to rescue HIV-1 viruses from non permissive epithelial
cells or HIV-1 IIIB from the cell surface of human RTEc
demonstrates that under the current experimental conditions
adherent viruses do not survive more than three weeks in culture.
Moreover, studies in transgenic mice demonstrate the presence of
all factors necessary for HIV -1 gene expression in RTEc [9–11].
However, the high viral titers used to infect cultured RTEc, in
addition to the low levels of p24 antigen produced by infected
RTEc, and the difficulties in detecting viral antigens in kidney
sections from patients with HIVAN, suggest that caution is
necessary before extrapolating these results to the in vivo situa-
tion. The low yield of infected urinary RTEc derived from the
urine of children with HIVAN also suggests that other factors, in
addition to the infection of RTEc, may play a relevant pathogenic
role in HIVAN. It is possible, however, that current in situ
hybridization techniques may not be sensitive enough to detect
low level replication of HIV in renal cells in vivo. Alternatively,
productively infected RTEc may succumb to viral infection and/or
become latently infected. This hypothesis may also explain our
difficulties in culturing and expanding infected primary RTEc
from the urine of children with HIVAN or RTEc infected in vitro.
The high number of regenerating RTEc present in renal sections
from children with HIVAN [46] suggests that infected cells may
be rapidly replaced.
An additional relevant finding of this study was the induction of
epithelial cell injury by HIV-1. The magnitude of the cell injury
depended on tissue culture conditions, degree of cell confluency,
type of renal tubular epithelium, and extracellular matrix used to
coat the culture dishes. Subconfluent cells, cells grown directly on
plastic, and human primary RTEc derived from non-infected
patients, were more sensitive to HIV-1 exposure than confluent
cells, cells grown on collagen coated dishes, or cells isolated from
HIV-1 infected patients. The mechanism(s) responsible for HIV-
induced injury of RTEc is currently under investigation. Mice
made transgenic with a replication defective subgenomic proviral
HIV-1 construct, manifest renal tubular epithelial cell injury in
correlation with the induction of high levels of HIV gene expres-
sion [9–11, 47]. In addition, cultured transgenic RTEc expressing
high levels of HIV genes grow slower than RTEc isolated from
their control littermates (Ray, unpublished data). Thus, HIV-1
infection or HIV-1 gene products, may have a direct growth
inhibitory effect in RTEc independent of other environmental
factors.
In summary, we have demonstrated that primary human RTEc
can be infected with primary HIV-1 isolates derived from children
with HIVAN through a CD4 independent pathway. Tissue mono-
nuclear cells may play an important role in this process and can
transfer the virus to epithelial cells. Moreover, infection and/or
expression of HIV-1 gene products inhibited the in vitro growth
and survival of primary RTEc. These findings suggest that the
renal epithelial degenerative changes present in children with
HIVAN may, at least in part, be explained by the infection of
RTEc by HIV-1.
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